GenoType MTBDRslLine Probe Assay Shortens Time to Diagnosis of Extensively Drug-Resistant Tuberculosis in a High-Throughput Diagnostic Laboratory

Mycobacterium tuberculosis Population Structure Determines the Outcome of Genetics-Based Second-Line Drug Resistance Testing

(2012) E. M. Streicher et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

GenoType MTBDRslperformance on clinical samples with diverse genetic background

(2012) Paolo Miotto et al.   EUROPEAN RESPIRATORY JOURNAL

Rise in rifampicin-monoresistant tuberculosis in Western Cape, South Africa

(2012) F. K. Mukinda et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Detection of Resistance to Second-Line Antituberculosis Drugs by Use of the Genotype MTBDRsl Assay: a Multicenter Evaluation and Feasibility Study

(2012) O. Ignatyeva et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Subpopulation Analysis of Heteroresistance to Fluoroquinolone in Mycobacterium tuberculosis Isolates from Beijing, China

(2012) X. Zhang et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Detecting Drug-Resistant Tuberculosis

(2012) Kim G. P. Hoek et al.   Molecular Diagnosis & Therapy

Evaluation of Genetic Mutations Associated with Mycobacterium tuberculosis Resistance to Amikacin, Kanamycin and Capreomycin: A Systematic Review

(2012) Sophia B. Georghiou et al.   PLoS One

Molecular Detection of Mutations Associated with First- and Second-Line Drug Resistance Compared with Conventional Drug Susceptibility Testing of Mycobacterium tuberculosis

(2011) Patricia J. Campbell et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Laboratory Diagnosis of Tuberculosis in Resource-Poor Countries: Challenges and Opportunities

(2011) L. M. Parsons et al.   CLINICAL MICROBIOLOGY REVIEWS

Evaluation of the GenoType® MTBDRsl assay for susceptibility testing of second-line anti-tuberculosis drugs

(2011) H. M. Said et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting

(2011) N. R. Gandhi et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

GenoType MTBDRslfor Molecular Detection of Second-Line-Drug and Ethambutol Resistance in Mycobacterium tuberculosis Strains and Clinical Samples

(2011) A. Lacoma et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Performance Assessment of the GenoType MTBDRslTest and DNA Sequencing for Detection of Second-Line and Ethambutol Drug Resistance among Patients Infected with Multidrug-Resistant Mycobacterium tuberculosis

(2011) Wei-Lun Huang et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Detection by GenoType MTBDRsl Test of Complex Mechanisms of Resistance to Second-Line Drugs and Ethambutol in Multidrug-Resistant Mycobacterium tuberculosis Complex Isolates

(2010) F. Brossier et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Evaluation of the MTBDRsl Test for Detection of Second-Line-Drug Resistance in Mycobacterium tuberculosis

(2010) V. S. Kiet et al.   JOURNAL OF CLINICAL MICROBIOLOGY

HIV Coinfection in Multidrug- and Extensively Drug-Resistant Tuberculosis Results in High Early Mortality

(2009) Neel R. Gandhi et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Mycobacterium tuberculosis Strains with Highly Discordant Rifampin Susceptibility Test Results

(2009) A. Van Deun et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Feasibility of the GenoType MTBDRsl Assay for Fluoroquinolone, Amikacin-Capreomycin, and Ethambutol Resistance Testing of Mycobacterium tuberculosis Strains and Clinical Specimens

(2009) D. Hillemann et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Drug-susceptibility testing in TB: current status and future prospects

(2009) Elvira Richter et al.   Expert Review of Respiratory Medicine

Rapid Molecular Screening for Multidrug-Resistant Tuberculosis in a High-Volume Public Health Laboratory in South Africa

(2008) Marinus Barnard et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Molecular Characterization of Ofloxacin-Resistant Mycobacterium tuberculosis Strains from Russia

(2008) I. Mokrousov et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY